Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Flutamide reduces hair growth better but has more side effects.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Spironolactone plus finasteride reduces hirsutism more effectively.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

The document describes a treatment for excessive hair growth in a teenage girl using medication and birth control, but does not report the results.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Birth control pills can help reduce mild to moderate acne in women.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.